Skip to main content
    S

    Si-Bone Inc (SIBN)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $23.44
    -0.70 (-2.90%)

    Market Cap: $1.06B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Si-Bone Inc (SIBN) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Si-Bone (SIBN) to earn -$0.34 per share in the fiscal year ending Dec 31, 2026, on revenue of $232.14M. Of 9 analysts, 9 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$0.29.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 9 ratings average 1.67, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.

    RatingAnalystsShare
    Strong Buy333.3%
    Buy666.7%
    Hold00.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    9

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 15.5%.

    Fiscal year ending Dec 31, 2026
    -$0.34
    EPS consensus, revenue $232.14M
    Fiscal year ending Dec 31, 2027
    -$0.29
    EPS consensus, revenue $268.12M

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.34-$0.36 to -$0.327$232.14M$231.83M to $232.90M9
    Dec 31, 2027-$0.29-$0.39 to -$0.227$268.12M$265.00M to $270.13M9

    Quarterly Estimates

    The EPS consensus falls from -$0.07 for the quarter ending Dec 31, 2026 to -$0.10 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.07-$0.09 to -$0.0511$69.24M$66.35M to $72.03M11
    Mar 31, 2027-$0.10-$0.15 to -$0.065$62.38M$60.70M to $64.04M6

    Estimate Revisions

    PeriodUp 30 daysDown 30 days
    Quarter ending Mar 31, 202720

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.40.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.34-$0.40-$0.40-$0.40-$0.40N/A
    Fiscal year ending Dec 31, 2027-$0.29-$0.33-$0.33-$0.33-$0.33N/A
    Quarter ending Mar 31, 2027-$0.10-$0.10-$0.10-$0.10-$0.10N/A

    Frequently Asked Questions About SIBN

    What is the SIBN stock forecast?

    Consensus analyst estimates put Si-Bone's EPS at -$0.34 for the fiscal year ending Dec 31, 2026, on revenue of $232.14M. The consensus rating from 9 analysts is Buy.

    How do analysts rate SIBN stock?

    Of 9 analysts covering Si-Bone, 3 rate it Strong Buy, 6 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from SIBN next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.34, with estimates from -$0.36 to -$0.32 from 7 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.29, with estimates from -$0.39 to -$0.22 from 7 analysts.

    What revenue do analysts expect from Si-Bone next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $232.14M, with estimates from $231.83M to $232.90M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $268.12M, with estimates from $265.00M to $270.13M.

    How many analysts cover SIBN?

    9 analysts rate Si-Bone stock, and 7 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.